{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:28:49Z","timestamp":1791152929731,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1492,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the United States. Metabolic syndrome is recognized as a risk factor for HCC and a postulated one for ICC. The magnitude of risk, however, has not been investigated on a population level in the United States. We therefore examined the association between metabolic syndrome and the development of these cancers. All persons diagnosed with HCC and ICC between 1993 and 2005 were identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. For comparison, a 5% sample of individuals residing in the same regions as the SEER registries of the cases was selected. The prevalence of metabolic syndrome as defined by the U.S. National Cholesterol Education Program Adult Treatment Panel III criteria, and other risk factors for HCC (hepatitis B virus, hepatitis C virus, alcoholic liver disease, liver cirrhosis, biliary cirrhosis, hemochromatosis, Wilson's disease) and ICC (biliary cirrhosis, cholangitis, cholelithiasis, choledochal cysts, hepatitis B virus, hepatitis C virus, alcoholic liver disease, cirrhosis, inflammatory bowel disease) were compared among persons who developed cancer and those who did not. Logistic regression was used to calculate odds ratios and 95% confidence intervals. The inclusion criteria were met by 3649 HCC cases, 743 ICC cases, and 195,953 comparison persons. Metabolic syndrome was significantly more common among persons who developed HCC (37.1%) and ICC (29.7%) than the comparison group (17.1%,<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001). In adjusted multiple logistic regression analyses, metabolic syndrome remained significantly associated with increased risk of HCC (odds ratio = 2.13; 95% confidence interval = 1.96-2.31,<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001) and ICC (odds ratio = 1.56; 95% confidence interval = 1.32-1.83,<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001).<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>Metabolic syndrome is a significant risk factor for development of HCC and ICC in the general U.S. population. (Hepatology 2011;)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.24397","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T13:31:02Z","timestamp":1304083862000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":452,"title":["Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database"],"prefix":"10.1097","volume":"54","author":[{"given":"Tania M.","family":"Welzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Graubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem B.","family":"El-Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"McGlynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20241202","doi-asserted-by":"crossref","first-page":"14851491","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"R2-10-20241202","doi-asserted-by":"crossref","first-page":"873875","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra and extrahepatic cholangiocarcinoma in the United States.","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R3-10-20241202","doi-asserted-by":"crossref","first-page":"13721380","DOI":"10.1053\/j.gastro.2004.07.020","article-title":"Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a populationbased study.","volume":"127","author":"Davila","year":"2004","journal-title":"Gastroenterology"},{"key":"R4-10-20241202","doi-asserted-by":"crossref","first-page":"12211228","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a populationbased casecontrol study.","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-10-20241202","doi-asserted-by":"crossref","first-page":"308321","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"R6-10-20241202","doi-asserted-by":"crossref","first-page":"372384","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLDNASH based on the EASL 2009 special conference.","volume":"53","author":"Ratziu","year":"2010","journal-title":"J Hepatol"},{"key":"R7-10-20241202","doi-asserted-by":"crossref","first-page":"18201832","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"R8-10-20241202","doi-asserted-by":"crossref","first-page":"113121","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a populationbased cohort study.","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"R9-10-20241202","doi-asserted-by":"crossref","first-page":"162168","DOI":"10.1159\/000282081","article-title":"The natural history of nonalcoholic fatty liver disease.","volume":"28","author":"Caldwell","year":"2010","journal-title":"Dig Dis"},{"key":"R10-10-20241202","doi-asserted-by":"crossref","first-page":"S99S112","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis.","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"R11-10-20241202","doi-asserted-by":"crossref","first-page":"56515661","DOI":"10.1002\/cncr.24687","article-title":"Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.","volume":"115","author":"Siegel","year":"2009","journal-title":"Cancer"},{"key":"R12-10-20241202","doi-asserted-by":"crossref","first-page":"722728","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.","volume":"143","author":"Hamaguchi","year":"2005","journal-title":"Ann Intern Med"},{"key":"R13-10-20241202","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"R14-10-20241202","doi-asserted-by":"crossref","first-page":"917923","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"R15-10-20241202","doi-asserted-by":"crossref","first-page":"16401645","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R16-10-20241202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gtc.2009.12.014","article-title":"The epidemiology of obesity.","volume":"39","author":"Nguyen","year":"2010","journal-title":"Gastroenterol Clin North Am"},{"key":"R17-10-20241202","first-page":"24442449","article-title":"Increasing prevalence of the metabolic syndrome among U.","volume":"27","author":"Ford","year":"2004","journal-title":"S Adults Diabetes Care"},{"key":"R18-10-20241202","doi-asserted-by":"crossref","first-page":"629636","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic.","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R19-10-20241202","doi-asserted-by":"crossref","first-page":"501510","DOI":"10.1016\/j.jhep.2008.10.030","article-title":"Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.","volume":"50","author":"Minervini","year":"2009","journal-title":"J Hepatol"},{"key":"R20-10-20241202","doi-asserted-by":"crossref","first-page":"18251832","DOI":"10.1111\/j.1440-1746.2005.04058.x","article-title":"Fatty liver and the metabolic syndrome among Shanghai adults.","volume":"20","author":"Fan","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-10-20241202","doi-asserted-by":"crossref","first-page":"865873","DOI":"10.1002\/hep.21327","article-title":"Longterm followup of patients with NAFLD and elevated liver enzymes.","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"R22-10-20241202","doi-asserted-by":"crossref","first-page":"685686","DOI":"10.1016\/j.jhep.2004.05.008","article-title":"Association of nonalcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.","volume":"41","author":"Bullock","year":"2004","journal-title":"J Hepatol"},{"key":"R23-10-20241202","doi-asserted-by":"crossref","first-page":"827834","DOI":"10.1097\/MEG.0b013e3282748ef2","article-title":"Primary liver cancers with nonalcoholic steatohepatitis.","volume":"19","author":"Hashizume","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R24-10-20241202","doi-asserted-by":"crossref","first-page":"17611766","DOI":"10.5858\/132.11.1761","article-title":"Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?","volume":"132","author":"Guzman","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R25-10-20241202","doi-asserted-by":"crossref","first-page":"194202","DOI":"10.1089\/met.2006.0018","article-title":"Is cholangiocarcinoma another complication of insulin resistance: a report of three cases.","volume":"5","author":"Michelini","year":"2007","journal-title":"Metab Syndr Relat Disord"},{"key":"R26-10-20241202","doi-asserted-by":"crossref","first-page":"IV318","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEERMedicare data: content, research applications, and generalizability to the United States elderly population.","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"R32-10-20241202","doi-asserted-by":"crossref","first-page":"18981904","DOI":"10.2337\/dc08-0423","article-title":"Metabolic syndrome and incident diabetes: current state of the evidence.","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"R33-10-20241202","doi-asserted-by":"crossref","first-page":"812819","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a metaanalysis.","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"R34-10-20241202","doi-asserted-by":"crossref","first-page":"403414","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and metaanalysis of longitudinal studies.","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R35-10-20241202","doi-asserted-by":"crossref","first-page":"19721978","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"R36-10-20241202","doi-asserted-by":"crossref","first-page":"192196","DOI":"10.1159\/000282085","article-title":"Chemokines as immune mediators of liver diseases related to the metabolic syndrome.","volume":"28","author":"Berres","year":"2010","journal-title":"Dig Dis"},{"key":"R37-10-20241202","doi-asserted-by":"crossref","first-page":"672690","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: the metabolic movers.","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R38-10-20241202","first-page":"774788","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.","volume":"52","author":"NeuschwanderTetri","year":"2010","journal-title":"Hepatology"},{"key":"R39-10-20241202","doi-asserted-by":"crossref","first-page":"229235","DOI":"10.1159\/000282094","article-title":"Molecular mechanisms of hepatic fibrosis in nonalcoholic steatohepatitis.","volume":"28","author":"Rombouts","year":"2010","journal-title":"Dig Dis"},{"key":"R40-10-20241202","doi-asserted-by":"crossref","first-page":"638641","DOI":"10.1002\/ijc.22283","article-title":"Risk factors for intrahepatic cholangiocarcinoma in a lowrisk population: a nationwide casecontrol study.","volume":"120","author":"Welzel","year":"2007","journal-title":"Int J Cancer"},{"key":"R41-10-20241202","first-page":"369380","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence.","volume":"4","author":"ElSerag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R42-10-20241202","doi-asserted-by":"crossref","first-page":"294299","DOI":"10.1159\/000282105","article-title":"Hepatitis C virusinduced steatosis: an overview.","volume":"28","author":"Negro","year":"2010","journal-title":"Dig Dis"},{"key":"R43-10-20241202","doi-asserted-by":"crossref","first-page":"17411745","DOI":"10.1093\/annonc\/mdp059","article-title":"Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection.","volume":"20","author":"Lagiou","year":"2009","journal-title":"Ann Oncol"},{"key":"R44-10-20241202","doi-asserted-by":"crossref","first-page":"30363043","DOI":"10.1002\/cncr.11427","article-title":"Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.","volume":"97","author":"Ohata","year":"2003","journal-title":"Cancer"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24397","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201108000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:03:42Z","timestamp":1733141022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201108000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24397","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13122956.14447054","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}